Aethlon Medical, Inc. (AEMD) Analysis

Aethlon Medical Inc (AEMD) reports progress in its Australian trial, cost-saving measures, and plans for future funding amid strategic shifts.

$AEMD off new headline - '' Global Chikungunya Virus Outbreak: CDC Issues Travel Warning For 16 Countries As Cases Cross 240,000 '' recent reverse split name with just 3m marketcap and 2m float & also has a catalyst in 3 days as well \- '' Aethlon Medical’s Hemopurifier has demonstrated in vitro the ability to capture Chikungunya virus '', “Additionally, in vitro, the Hemopurifier has been demonstrated to capture Ebola, Marburg virus, Zika, Lassa, MERS-CoV, Cytomegalovirus, Epstein-Barr,...

$AEMD off new headline - '' Global Chikungunya Virus Outbreak: CDC Issues Travel Warning For 16 Countries As Cases Cross 240,000 '' recent reverse split name with just 3m marketcap and 2m float & also has a catalyst in 3 days as well \- '' Aethlon Medical’s Hemopurifier has demonstrated in vitro the ability to capture Chikungunya virus '', “Additionally, in vitro, the Hemopurifier has been demonstrated to capture Ebola, Marburg virus, Zika, Lassa, MERS-CoV, Cytomegalovirus, Epstein-Barr,...

$AEMD off new headline - '' Global Chikungunya Virus Outbreak: CDC Issues Travel Warning For 16 Countries As Cases Cross 240,000 '' recent reverse split name with just 3m marketcap and 2m float & also has a catalyst in 3 days as well \- '' Aethlon Medical’s Hemopurifier has demonstrated in vitro the ability to capture Chikungunya virus '', “Additionally, in vitro, the Hemopurifier has been demonstrated to capture Ebola, Marburg virus, Zika, Lassa, MERS-CoV, Cytomegalovirus, Epstein-Barr,...